close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hologic, Inc. - Common Stock (NQ:HOLX)

73.99 +0.10 (+0.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Hologic, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
HALPER SADEH LLC ENCOURAGES MTSR, HOLX, MRUS SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. 
From Halper Sadeh LLC
Via GlobeNewswire
Hologic Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX
From Kahn Swick & Foti, LLC
Via Business Wire
Halper Sadeh LLC Investigates HOLX, WOW, AL, GES on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
HOLX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Hologic, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market
Via Investor Brand Network
Topics Artificial Intelligence Death
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hologic, Inc. (Nasdaq – HOLX), TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH)
From Brodsky & Smith LLC
Via GlobeNewswire
Hologic to be Acquired by Blackstone and TPG for up to $79 per Share
From Hologic, Inc.
Via Business Wire
Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market
EQNX::TICKER_START (OTCQB:IZOZF),(CSE:IZO),(NASDAQ:HOLX),(NASDAQ:GEHC),(NASDAQ:NNOX),(NYSE:ORCL) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence Death
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025
From Hologic, Inc.
Via Business Wire
Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis
From Hologic, Inc.
Via Business Wire
New Survey Results Underscore the Need to #BustTheMyth About Mammograms
From Hologic, Inc.
Via Business Wire
InvestorNewsBreaks – VolitionRx (NYSE American: VNRX) Signs Co-Marketing and Services Agreement with Hologic (NASDAQ: HOLX)
Via Investor Brand Network
New Data on Hologic’s AI-Powered Mammography Technology to Be Presented at EUSOBI
From Hologic, Inc.
Via Business Wire
Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference
From Hologic, Inc.
Via Business Wire
Hologic Announces Financial Results for Third Quarter of Fiscal 2025
From Hologic, Inc.
Via Business Wire
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025
From Hologic, Inc.
Via Business Wire
Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients
From Hologic, Inc.
Via Business Wire
Hologic Announces Financial Results for Second Quarter of Fiscal 2025
From Hologic, Inc.
Via Business Wire
Groundbreaking New Data on Hologic’s AI-Powered Mammography Technology to Be Presented at SBI
From Hologic, Inc.
Via Business Wire
Hologic Details Environmental, Social and Governance Efforts — Including Expanded Environmental Ambitions — in New Sustainability Report
From Hologic, Inc.
Via Business Wire
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025
From Hologic, Inc.
Via Business Wire
Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference
From Hologic, Inc.
Via Business Wire
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay
From Hologic, Inc.
Via Business Wire
Hologic Announces Financial Results for First Quarter of Fiscal 2025
From Hologic, Inc.
Via Business Wire
New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide
From Hologic, Inc.
Via Business Wire
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025
From Hologic, Inc.
Via Business Wire
Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
From Hologic, Inc.
Via Business Wire
Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025
From Hologic, Inc.
Via Business Wire
Hologic Completes Acquisition of Gynesonics, Inc.
From Hologic, Inc.
Via Business Wire
Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC
From Hologic, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today